Goldman Sachs tips value shares as better bet on a Covid-19 vaccine than cyclicals

Author: Eamonn Sheridan | Category: News

This via a Bloomberg piece from GS:

  • "The consensus view of investors is cyclicals will outperform when a vaccine is identified," the strategists wrote. "However, the correlation of returns with the prospects for a vaccine suggest value rather than cyclicals is the better tactical expression of this view."
As for timing, this:
  • Vaccine catalysts may coincide with the upcoming U.S. election, which may also provide a tailwind to value in the near term, the strategists said.
Here is the Bloomberg link for more
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose